ArticleScientific reports2015

Inhibition of miR-29 has a significant lipid-lowering benefit through suppression of lipogenic programs in liver.

C Lisa Kurtz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.